Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Guangzhou Lianrui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” approved and issued by the State Drug Administration for the dry suspension of etrapopa ethanolamine. This time, the company obtained an etrapopa ethanolamine dry suspension registration certificate, indicating that the company is qualified to sell drugs of this specification in the domestic market, which will further enrich the company's product pipeline and product categories, and enhance the company's core competitiveness.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.